Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-04-09 4:54 pm Purchase | 2021-03-24 | 13D | Adverum Biotechnologies, Inc. ADVM | Sonic Fund II L.P. | 663,143 6.800% | 50,000 (+8.15%) | Filing History |
| 2021-03-18 2:21 pm Purchase | 2021-03-15 | 13D | Adverum Biotechnologies, Inc. ADVM | Sonic Fund II L.P. | 613,143 6.300% | 91,528 (+17.55%) | Filing History |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM | RA CAPITAL MANAGEMENT L.P. | 950,238 9.700% | 950,238 (New Position) | Filing History |
| 2021-02-16 3:46 pm Purchase | 2020-12-17 | 13G | Adverum Biotechnologies, Inc. ADVM | Sonic Fund II L.P. | 521,615 5.400% | 96,887 (+22.81%) | Filing History |
| 2021-02-12 4:37 pm Purchase | 2020-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM | ORBIMED ADVISORS LLC | 484,525 4.970% | 90,116 (+22.85%) | Filing History |
| 2021-02-12 09:17 am Purchase | 2020-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM | RTW Investments, LP | 722,736 7.420% | 84,076 (+13.16%) | Filing History |
| 2021-02-12 08:00 am Purchase | 2020-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM | Avoro Capital Advisors LLC | 800,000 8.200% | 275,000 (+52.38%) | Filing History |
| 2021-01-28 5:56 pm Purchase | 2020-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM | BlackRock Inc. BLK | 704,277 7.200% | 252,434 (+55.87%) | Filing History |